Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Treatment with short acting β2 agonists for exacerbations of COPD results in clinical
improvement. It has not been established whether combining short acting β2 agonists to other
bronchodilators is more effective than β2 agonists alone. The aim of this study is to
evaluate the efficacy and safety of combination of SABA and MgSO4 in comparison to SABA and
ipratropium bromide (IB) in patients attending the emergency department for AECOPD.